Share Market News Live

Global Tumour Ablation Market Size & Worth USD 3.5 Billion By 2024

Some of the other key players operating in this market are Galil Medical, Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, Inc., BVM Medical Limited, AngioDynamics, Inc., COMSOL Inc., Boston Scientific Corporation, EDAP TMS S.A. and, HealthTronics, Inc. among other companies.
Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

The Global Tumour Ablation Market has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024.

Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample?dbmr=global-tumour-ablation-market

The global tumour ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics. However ablation technology can only be used to treat tumours with size less than 3cm, owing to the healthy tissue damage caused by it. With the advent of guidance mechanisms such as ultrasounds and MRI the accuracy of the treatment has increased significantly in the past 5 years.

The global tumour ablation market is segmented based on product types, cancer types, end-user and geography.

The global tumour ablation market  is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation. All ablation techniques are percutaneous except HIFU which is administered transcutaneously.

On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types. 

Based on end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others.

Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying?dbmr=global-tumour-ablation-market

Based on geography the Global Tumour Ablation Market is segmented into:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Rest of the World

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/ablation-devices-medical-devices/global-tumour-ablation-market

The tumour ablation market’s major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015, Medtronic acquired Covidien to strengthen its leadership in medical devices industry among others. The report includes market shares of tumour ablation market for global, Europe, North America, Asia Pacific and Rest of the World.

Some of the major companies operating in this market are:

  • Galil Medical, Inc.
  • Perseon Corporation
  • NeuWave Medical, Inc.
  • Koninklijke Philips N.V.
  • INTIO Inc.
  • Mermaid Medical A/S
  • SonaCare Medical
  • LLC
  • DFINE, Inc.
  • Misonix, Inc.
  • BVM Medical Limited
  • AngioDynamics, Inc.
  • COMSOL Inc.
  • Boston Scientific Corporation
  • EDAP TMS S.A.
  • HealthTronics, Inc.

Table of Content:

1. INTRODUCTION

      1.1. OVERVIEW OF THE TUMOUR ABLATION MARKET

      1.2. MARKET SEGMENTATION & COVERAGE

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS

       2.2. ARRIVING AT THE TUMOUR ABLATION MARKET SIZE

                        2.2.1. MARKET CRACKDOWN APPROACH

                        2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                        2.2.3. DATA TRIANGULATION

                        2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                        2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

                        2.2.6. PORTER’S FIVE FORCES MATRIX

                        2.2.7. PEST ANALYSIS

                        2.2.8. EPIDEMIOLOGY FORECASTING MODELS

       2.3. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. MARKET OVERVIEW

       4.1. OVERVIEW

       4.2. TUMOUR ABLATION MARKET: KEY PRIMARY INSIGHTS

       4.3. DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX

       4.4. KEY MARKET FINDINGS

       4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. TUMOUR ABLATION MARKET, BY TYPE

       5.1. OVERVIEW

       5.2. TUMOUR ABLATION SYSTEMS

                       5.2.1.      RADIO FREQUENCY ABLATION SYSTEM (RFA)

                       5.2.2.      MICROWAVE ABLATION SYSTEM

                       5.2.3.      HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)

                       5.2.4.      LASER ABLATION SYSTEM

                       5.2.5.      CRYOABLATION

       5.3. IMAGE GUIDANCE PRODUCTS

       5.4. ACCESSORIES

6. TUMOUR ABLATION MARKET, BY CANCER TYPE

       6.1. OVERVIEW

       6.2. LIVER CANCER

       6.3. BRAIN CANCER

       6.4. LUNG CANCER

       6.5. BONE CANCER

       6.6. KIDNEY CANCER

       6.7. PANCREATIC CANCER

       6.8. BREAST CANCER

       6.9. OTHERS

7. TUMOR ABLATION MARKET, BY END-USER

7.1. OVERVIEW 

7.2. HOSPITALS

7.3. ONCOLOGY CLINIC

7.4. OTHERS

8. TUMOUR ABLATION MARKET, BY GEOGRAPHY

       8.1. COUNTRYWISE TUMOUR ABLATION MARKET,  (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                       8.1.1.      NORTH AMERICA

                                          8.1.1.1.      U.S.

                                          8.1.1.2.      CANADA

                                          8.1.1.3.      MEXICO

                       8.1.2.      EUROPE

                                           8.1.2.1.      GERMANY

                                           8.1.2.2.      FRANCE

                                           8.1.2.3.      U.K.

                                           8.1.2.4.      ITALY

                                           8.1.2.5.      SPAIN

                                           8.1.2.6.      RUSSIA

                                           8.1.2.7.      TURKEY

                                           8.1.2.8.      BELGIUM

                                           8.1.2.9.      NETHERLANDS

                                           8.1.2.10.    SWITZERLAND

                                           8.1.2.11.    REST OF EUROPE

                       8.1.3.      ASIA-PACIFIC (APAC)

                                           8.1.3.1.      JAPAN

                                           8.1.3.2.      CHINA

                                           8.1.3.3.      SOUTH KOREA

                                           8.1.3.4.      INDIA

                                           8.1.3.5.      AUSTRALIA

                                           8.1.3.6.      SINGAPORE

                                           8.1.3.7.      THAILAND

                                           8.1.3.8.      MALAYSIA

                                           8.1.3.9.      REST OF APAC

                       8.1.4.    LATIN AMERICA

                                         8.1.4.1.     BRAZIL

                                         8.1.4.2.     REST OF LATIN AMERICA

                       8.1.5.    REST OF THE WORLD

       8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9. TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE

       9.1. GLOBAL TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

       9.2. NORTH AMERICA TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

       9.3. EUROPE TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

       9.4. APAC TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

       9.5. MERGERS & ACQUISITIONS

       9.6. NEW PRODUCT DEVELOPMENT & APPROVALS

       9.7. EXPANSIONS

       9.8. REGULATORY CHANGES

       9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10. TUMOUR ABLATION MARKET, COMPANY PROFILES

       10.1. MEDTRONIC

                          10.1.1   OVERVIEW

                          10.1.2   SWOT ANALYSIS

                          10.1.3   PRODUCT PORTFOLIO

                          10.1.4   REVENUE ANALYSIS

                          10.1.5   ANALYSTS VIEW

       10.2. GALIL MEDICAL, INC.

                           10.2.1   OVERVIEW

                           10.2.2   SWOT ANALYSIS

                           10.2.3   PRODUCT PORTFOLIO

                           10.2.4   REVENUE ANALYSIS

                           10.2.5   ANALYSTS VIEW

       10.3  PERSEON CORPORATION

                          10.3.1   OVERVIEW

                          10.3.2   SWOT ANALYSIS

                          10.3.3   PRODUCT PORTFOLIO

                           10.3.4   REVENUE ANALYSIS

                           10.3.5   ANALYST VIEW

       10.4  NEUWAVE MEDICAL, INC.

                          10.4.1   OVERVIEW

                          10.4.2   SWOT ANALYSIS

                          10.4.3   PRODUCT PORTFOLIO

                          10.4.4   REVENUE ANALYSIS

                          10.4.5   ANALYSTS VIEW

       10.5. KONINKLIJKE PHILIPS N.V.

                          10.5.1   OVERVIEW

                          10.5.2   SWOT ANALYSIS

                          10.5.3   PRODUCT PORTFOLIO

                          10.5.4   REVENUE ANALYSIS

                          10.5.5   ANALYSTS VIEW

       10.6. INTIO INC.

                   10.6.1   OVERVIEW

                          10.6.2   SWOT ANALYSIS

                          10.6.3   PRODUCT PORTFOLIO

                          10.6.4   REVENUE ANALYSIS

                          10.6.5   ANALYSTS VIEW

       10.7. MERMAID MEDICAL A/S

                          10.7.1   OVERVIEW

                          10.7.2   SWOT ANALYSIS

                           10.7.3   PRODUCT PORTFOLIO

                           10.7.4   REVENUE ANALYSIS

                           10.7.5   ANALYSTS VIEW

       10.8. SONACARE MEDICAL, LLC

                           10.8.1   OVERVIEW

                           10.8.2   SWOT ANALYSIS

                           10.8.3   PRODUCT PORTFOLIO

                           10.8.4   REVENUE ANALYSIS

                           10.8.5   ANALYSTS VIEW

       10.9. DFINE, INC.

                   10.9.1. OVERVIEW

                   10.9.2. SWOT ANALYSIS

                   10.9.3. PRODUCT PORTFOLIO

                   10.9.4. REVENUE ANALYSIS

                   10.9.5. ANALYSTS VIEW

       10.10. MISONIX, INC.

                   10.10.1. OVERVIEW

                   10.10.2. SWOT ANALYSIS

                   10.10.3. PRODUCT PORTFOLIO

                   10.10.4. REVENUE ANALYSIS

                   10.10.5. ANALYSTS VIEW

       10.11. BVM MEDICAL LIMITED

                   10.11.1. OVERVIEW

                   10.11.2. SWOT ANALYSIS

                   10.11.3. PRODUCT PORTFOLIO

                   10.11.4. REVENUE ANALYSIS

                   10.11.5. ANALYSTS VIEW

       10.12. ANGIODYNAMICS, INC.

                   10.12.1. OVERVIEW

                   10.12.2. SWOT ANALYSIS

                   10.12.3. PRODUCT PORTFOLIO

                   10.12.4. REVENUE ANALYSIS

                   10.12.5. ANALYSTS VIEW

       10.13. COMSOL INC.

                   10.13.1. OVERVIEW

                   10.13.2. SWOT ANALYSIS

                   10.13.3. PRODUCT PORTFOLIO

                   10.13.4. REVENUE ANALYSIS

                   10.13.5. ANALYSTS VIEW

       10.14. BOSTON SCIENTIFIC CORPORATION

                   10.14.1. OVERVIEW

                   10.14.2. SWOT ANALYSIS

                   10.14.3. PRODUCT PORTFOLIO

                   10.14.4. REVENUE ANALYSIS

                   10.14.5. ANALYSTS VIEW

       10.15. EDAP TMS S.A.

                   10.10.1. OVERVIEW

                   10.10.2. SWOT ANALYSIS

                   10.10.3. PRODUCT PORTFOLIO

                   10.10.4. REVENUE ANALYSIS

                   10.10.5. ANALYSTS VIEW

       10.16. HEALTHTRONICS, INC.

                   10.11.1. OVERVIEW

                   10.11.2. SWOT ANALYSIS

                   10.11.3. PRODUCT PORTFOLIO

                   10.11.4. REVENUE ANALYSIS

                   10.11.5. ANALYSTS VIEW

11. APPENDIX

       11.1. RELATED REPORTS

       11.2. CUSTOMIZABLE OPTIONS

       11.3. SOURCE SHEET

       11.4. BIBLIOGRAPHY

Related Report

Global Infection Control Market – Trends and Forecast to 2024

Global Infection Control Market, By Type (Disinfection (Medical Nonwovens, Disinfectants, Disinfectors (Washer, Flusher, U.V. Rays), Disinfectant Wipes, Endoscope Reprocessors), Sterilization (Products (Heat, Low Temperature, Radiation, Filtration), Services)), By Application, By End-User (Hospitals, Medical Device Manufacturers, Pharmaceutical Manufacturers, Food and Beverage Industry, Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2024

Report Access:  http://databridgemarketresearch.com/reports/medical-devices/healthcare-manufacturing/global-infection-control-market-trends-forecast-2024

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Investor: [email protected]

Visit Blog: http://databridgemarketresearch.com/blog/  

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Ankit Singh
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/medical-devices/ablation-devices-medical-devices/global-tumour-ablation-market

Calendar

August 2017
M T W T F S S
« Jul    
 123456
78910111213
14151617181920
21222324252627
28293031